Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications

Eric A. Hunt, Angeliki Moutsiopoulou, Stephanie Ioannou, Katelyn Ahern, Kristen Woodward, Emre Dikici, Sylvia Daunert, Sapna K Deo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Gaussia luciferase (Gluc)-with its many favorable traits such as small size, bright emission, and exceptional stability-has become a prominent reporter protein for a wide range of bioluminescence-based detection applications. The ten internal cysteine residues crucial to functional structure formation, however, make expression of high quantities of soluble protein in bacterial systems difficult. In addition to this challenge, the current lack of structural data further complicates the use of Gluc for in vitro applications, such as biosensors, or cellular delivery, both of which rely heavily on robust and reproducible bioconjugation techniques. While Gluc is already appreciably small for a luciferase, a reduction in size that still retains significant bioluminescent activity, in conjunction with a more reproducible bioorthogonal method of chemical modification and facile expression in bacteria, would be very beneficial in biosensor design and cellular transport studies. We have developed truncated variants of Gluc, which maintain attractive bioluminescent features, and have characterized their spectral and kinetic properties. These variants were purified in high quantities from a bacterial system. Additionally, a C-Terminal linker has been incorporated into these variants that can be used for reliable, specific modification through tyrosine-based bioconjugation techniques, which leave the sensitive network of cysteine residues undisturbed.

Original languageEnglish (US)
Article number26814
JournalScientific Reports
Volume6
DOIs
StatePublished - Jun 8 2016

Fingerprint

Luciferases
Tyrosine
Biosensing Techniques
Cysteine
Bacterial Proteins
Bacteria
Proteins

ASJC Scopus subject areas

  • General

Cite this

Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications. / Hunt, Eric A.; Moutsiopoulou, Angeliki; Ioannou, Stephanie; Ahern, Katelyn; Woodward, Kristen; Dikici, Emre; Daunert, Sylvia; Deo, Sapna K.

In: Scientific Reports, Vol. 6, 26814, 08.06.2016.

Research output: Contribution to journalArticle

Hunt, Eric A. ; Moutsiopoulou, Angeliki ; Ioannou, Stephanie ; Ahern, Katelyn ; Woodward, Kristen ; Dikici, Emre ; Daunert, Sylvia ; Deo, Sapna K. / Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications. In: Scientific Reports. 2016 ; Vol. 6.
@article{e89d1c8a535a48d2af79e6e04cef4668,
title = "Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications",
abstract = "Gaussia luciferase (Gluc)-with its many favorable traits such as small size, bright emission, and exceptional stability-has become a prominent reporter protein for a wide range of bioluminescence-based detection applications. The ten internal cysteine residues crucial to functional structure formation, however, make expression of high quantities of soluble protein in bacterial systems difficult. In addition to this challenge, the current lack of structural data further complicates the use of Gluc for in vitro applications, such as biosensors, or cellular delivery, both of which rely heavily on robust and reproducible bioconjugation techniques. While Gluc is already appreciably small for a luciferase, a reduction in size that still retains significant bioluminescent activity, in conjunction with a more reproducible bioorthogonal method of chemical modification and facile expression in bacteria, would be very beneficial in biosensor design and cellular transport studies. We have developed truncated variants of Gluc, which maintain attractive bioluminescent features, and have characterized their spectral and kinetic properties. These variants were purified in high quantities from a bacterial system. Additionally, a C-Terminal linker has been incorporated into these variants that can be used for reliable, specific modification through tyrosine-based bioconjugation techniques, which leave the sensitive network of cysteine residues undisturbed.",
author = "Hunt, {Eric A.} and Angeliki Moutsiopoulou and Stephanie Ioannou and Katelyn Ahern and Kristen Woodward and Emre Dikici and Sylvia Daunert and Deo, {Sapna K}",
year = "2016",
month = "6",
day = "8",
doi = "10.1038/srep26814",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications

AU - Hunt, Eric A.

AU - Moutsiopoulou, Angeliki

AU - Ioannou, Stephanie

AU - Ahern, Katelyn

AU - Woodward, Kristen

AU - Dikici, Emre

AU - Daunert, Sylvia

AU - Deo, Sapna K

PY - 2016/6/8

Y1 - 2016/6/8

N2 - Gaussia luciferase (Gluc)-with its many favorable traits such as small size, bright emission, and exceptional stability-has become a prominent reporter protein for a wide range of bioluminescence-based detection applications. The ten internal cysteine residues crucial to functional structure formation, however, make expression of high quantities of soluble protein in bacterial systems difficult. In addition to this challenge, the current lack of structural data further complicates the use of Gluc for in vitro applications, such as biosensors, or cellular delivery, both of which rely heavily on robust and reproducible bioconjugation techniques. While Gluc is already appreciably small for a luciferase, a reduction in size that still retains significant bioluminescent activity, in conjunction with a more reproducible bioorthogonal method of chemical modification and facile expression in bacteria, would be very beneficial in biosensor design and cellular transport studies. We have developed truncated variants of Gluc, which maintain attractive bioluminescent features, and have characterized their spectral and kinetic properties. These variants were purified in high quantities from a bacterial system. Additionally, a C-Terminal linker has been incorporated into these variants that can be used for reliable, specific modification through tyrosine-based bioconjugation techniques, which leave the sensitive network of cysteine residues undisturbed.

AB - Gaussia luciferase (Gluc)-with its many favorable traits such as small size, bright emission, and exceptional stability-has become a prominent reporter protein for a wide range of bioluminescence-based detection applications. The ten internal cysteine residues crucial to functional structure formation, however, make expression of high quantities of soluble protein in bacterial systems difficult. In addition to this challenge, the current lack of structural data further complicates the use of Gluc for in vitro applications, such as biosensors, or cellular delivery, both of which rely heavily on robust and reproducible bioconjugation techniques. While Gluc is already appreciably small for a luciferase, a reduction in size that still retains significant bioluminescent activity, in conjunction with a more reproducible bioorthogonal method of chemical modification and facile expression in bacteria, would be very beneficial in biosensor design and cellular transport studies. We have developed truncated variants of Gluc, which maintain attractive bioluminescent features, and have characterized their spectral and kinetic properties. These variants were purified in high quantities from a bacterial system. Additionally, a C-Terminal linker has been incorporated into these variants that can be used for reliable, specific modification through tyrosine-based bioconjugation techniques, which leave the sensitive network of cysteine residues undisturbed.

UR - http://www.scopus.com/inward/record.url?scp=84976416819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976416819&partnerID=8YFLogxK

U2 - 10.1038/srep26814

DO - 10.1038/srep26814

M3 - Article

C2 - 27271118

AN - SCOPUS:84976416819

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 26814

ER -